Anzeige
Mehr »
Login
Montag, 27.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
US-Präsident setzt auf die Solana Blockchain! Diese Krypto-Perle profitiert enorm!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
976 Leser
Artikel bewerten:
(2)

Open source innovation recognised by royalty as Payara wins prestigious Queen's Award for Enterprise

Finanznachrichten News

LONDON and WORCESTER, England, April 29, 2021 /PRNewswire/ -- Micro-multinational open source software company, Payara Services, has been commended for its achievements within global trading and exporting with the Queen's Award for Enterprise for International Trade.

Payara wins Queens Award for Enterprise (PRNewsfoto/Payara)

Now in its 55th year, the Queen's Award for Enterprise: International Trade is the UK's most prestigious business award, honouring organisations that have excelled in overseas exports whilst maintaining the highest standards in social, economic, and environmental activity.

Payara's win attests to the growing success of the open source software business model. Payara's open source product offering, the Payara Platform, is based on the global initiatives of the Jakarta EE and MicroProfile standards. Community users can download the Payara Platform Community Edition for their development projects and containerized Jakarta EE and MicroProfile applications, while the fully supported, subscription based Payara Enterprise Edition is designed for mission critical systems in production and containerized Jakarta EE and MicroProfile applications.

As one of just 205 businesses across the country to have received this accolade personally approved by Her Majesty The Queen, often called the 'knighthood for businesses', Payara can utilise the esteemed Queen's Award emblem within its marketing and promotional activity for the next five years.

Steve Millidge, Founder and CEO of Payara Services Ltd, commented: "We're thrilled to win a Queen's Award for International Trade. Payara was born global and has team members in many countries. This award recognises their commitment to the mission of delivering trusted, supported, enterprise software to customers worldwide."

Payara's Marketing Manager, Dominika Tasarz-Sochacka, added: "This prestigious award enhances our global reputation and builds on the exceptional growth we've experienced overseas in the last three years."

Since it was founded in 2016, Payara has implemented a strategy for overseas trade, with 95% of its services currently exported to a total of nine countries, including the USA, Japan, South Africa, and Germany.

Headquartered in Worcestershire, with a secondary EU office in Funchal, Portugal, Payara Services is recognised for its creation of innovative infrastructure software including the delivery of 24/7 production, development and migration support to customers around the world, including BMW Group, Hermes, and Rakuten Card.

The firm's leading team of tech experts - or 'Payarans' - have worked incredibly hard to increase annual revenue by 107% over the last three years, with export sales more than doubling from 33% to 75%. The Payara Server has now become one of the fastest-growing open source platforms globally, with a community of over 320,000 users.

Payara continues to expand its global customer base to reach new markets and has several innovative projects in the pipeline, including the Payara Cloud. September of 2021, Payara Cloud is the next generation of cloud-native application server and all-in-one PaaS provides a more efficient way to run Jakarta EE apps on the cloud with no Kubernetes knowledge required.

https://www.payara.fish
https://www.gov.uk/queens-awards-for-enterprise

Photo - https://mma.prnewswire.com/media/1497916/Payara_Queens_Award_for_Enterprise.jpg

© 2021 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.